Leading article
Alpha-1 antitrypsin deficiency
| The first 150 words of the full text of this article appear below. |
| |
Introduction |
|---|
-1 antitrypsin is synthesised in the liver and protects lung
alveolar tissues from destruction by neutrophil elastase.1
-1 antitrypsin deficiency is a common autosomal recessive condition (1:1600 to 1:1800) in which liver disease results from retention of
abnormal polymerised
-1 antitrypsin in the endoplasmic reticulum of
hepatocytes, and emphysema results from alveolar wall damage. The
clinical consequences of
-1 antitrypsin deficiency in childhood are
haemorrhagic disease in infancy, cholestasis in infancy, or chronic
liver disease. Lung disease attributable to
-1 antitrypsin deficiency does not occur in childhood, but is closely linked to
smoking in adults. Membranoproliferative glomerulonephritis, panniculitis, and necrotising vasculitis are associations with
-1
antitrypsin deficiency in adult life.2-4 Diagnostic
methods are summarised in table 1.
| Table Removed (Available Only in the Full Text) |
| |
Phenotypes |
|---|
-1 antitrypsin is a protease inhibitor, and common
Pi variants have been named by their
electrophoretic mobility. PiM, of which there are several minor
variants, is the normal protein. PiZ, the mutant
This article has been cited by other articles:
-
Kelly, D A
(2002). Managing liver failure. Postgrad. Med. J.
78: 660-667
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



